A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module Article Swipe
Sanjida Mowla
,
Ian Kracalik
,
Mathew R. P. Sapiano
,
Lynne O'Hearn
,
Chester Andrzejewski
,
Sridhar V. Basavaraju
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.tmrv.2021.03.003
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.tmrv.2021.03.003
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.tmrv.2021.03.003
- OA Status
- green
- Cited By
- 25
- References
- 24
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3152345913
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3152345913Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.tmrv.2021.03.003Digital Object Identifier
- Title
-
A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance ModuleWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-04-01Full publication date if available
- Authors
-
Sanjida Mowla, Ian Kracalik, Mathew R. P. Sapiano, Lynne O'Hearn, Chester Andrzejewski, Sridhar V. BasavarajuList of authors in order
- Landing page
-
https://doi.org/10.1016/j.tmrv.2021.03.003Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/8175014Direct OA link when available
- Concepts
-
Apheresis, Medicine, Platelet, Adverse effect, Platelet transfusion, Whole blood, Sepsis, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
25Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 4, 2023: 7, 2022: 7, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3152345913 |
|---|---|
| doi | https://doi.org/10.1016/j.tmrv.2021.03.003 |
| ids.doi | https://doi.org/10.1016/j.tmrv.2021.03.003 |
| ids.mag | 3152345913 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33934903 |
| ids.openalex | https://openalex.org/W3152345913 |
| fwci | 2.07380492 |
| mesh[0].qualifier_ui | Q000009 |
| mesh[0].descriptor_ui | D001781 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | adverse effects |
| mesh[0].descriptor_name | Blood Component Removal |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D001792 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Blood Platelets |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D058731 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Blood Safety |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D003695 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Delivery of Health Care |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D013672 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Technology |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D001781 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Blood Component Removal |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D001792 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Blood Platelets |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D058731 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Blood Safety |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D003695 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Delivery of Health Care |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D013672 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Technology |
| mesh[12].qualifier_ui | Q000009 |
| mesh[12].descriptor_ui | D001781 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | adverse effects |
| mesh[12].descriptor_name | Blood Component Removal |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D001792 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Blood Platelets |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D058731 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Blood Safety |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D003695 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Delivery of Health Care |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D013672 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Technology |
| type | review |
| title | A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module |
| biblio.issue | 2 |
| biblio.volume | 35 |
| biblio.last_page | 84 |
| biblio.first_page | 78 |
| topics[0].id | https://openalex.org/T10693 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9991000294685364 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2704 |
| topics[0].subfield.display_name | Biochemistry |
| topics[0].display_name | Blood transfusion and management |
| topics[1].id | https://openalex.org/T12735 |
| topics[1].field.id | https://openalex.org/fields/14 |
| topics[1].field.display_name | Business, Management and Accounting |
| topics[1].score | 0.9983000159263611 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1405 |
| topics[1].subfield.display_name | Management of Technology and Innovation |
| topics[1].display_name | Blood donation and transfusion practices |
| topics[2].id | https://openalex.org/T11660 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980999827384949 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2720 |
| topics[2].subfield.display_name | Hematology |
| topics[2].display_name | Blood groups and transfusion |
| is_xpac | False |
| apc_list.value | 4110 |
| apc_list.currency | USD |
| apc_list.value_usd | 4110 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776738589 |
| concepts[0].level | 3 |
| concepts[0].score | 0.846546471118927 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q618446 |
| concepts[0].display_name | Apheresis |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8285033702850342 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C89560881 |
| concepts[2].level | 2 |
| concepts[2].score | 0.8067620992660522 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q101026 |
| concepts[2].display_name | Platelet |
| concepts[3].id | https://openalex.org/C197934379 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6897029280662537 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[3].display_name | Adverse effect |
| concepts[4].id | https://openalex.org/C2776689292 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5061666369438171 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q23925170 |
| concepts[4].display_name | Platelet transfusion |
| concepts[5].id | https://openalex.org/C1621761 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4355936646461487 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7997549 |
| concepts[5].display_name | Whole blood |
| concepts[6].id | https://openalex.org/C2778384902 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4323592185974121 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q183134 |
| concepts[6].display_name | Sepsis |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4306963086128235 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/apheresis |
| keywords[0].score | 0.846546471118927 |
| keywords[0].display_name | Apheresis |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8285033702850342 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/platelet |
| keywords[2].score | 0.8067620992660522 |
| keywords[2].display_name | Platelet |
| keywords[3].id | https://openalex.org/keywords/adverse-effect |
| keywords[3].score | 0.6897029280662537 |
| keywords[3].display_name | Adverse effect |
| keywords[4].id | https://openalex.org/keywords/platelet-transfusion |
| keywords[4].score | 0.5061666369438171 |
| keywords[4].display_name | Platelet transfusion |
| keywords[5].id | https://openalex.org/keywords/whole-blood |
| keywords[5].score | 0.4355936646461487 |
| keywords[5].display_name | Whole blood |
| keywords[6].id | https://openalex.org/keywords/sepsis |
| keywords[6].score | 0.4323592185974121 |
| keywords[6].display_name | Sepsis |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.4306963086128235 |
| keywords[7].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1016/j.tmrv.2021.03.003 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S162247841 |
| locations[0].source.issn | 0887-7963, 1532-9496 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0887-7963 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Transfusion Medicine Reviews |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Transfusion Medicine Reviews |
| locations[0].landing_page_url | https://doi.org/10.1016/j.tmrv.2021.03.003 |
| locations[1].id | pmid:33934903 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Transfusion medicine reviews |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33934903 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8175014 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Transfus Med Rev |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8175014 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5085610975 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9305-9228 |
| authorships[0].author.display_name | Sanjida Mowla |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[0].affiliations[0].raw_affiliation_string | Oak Ridge Institute for Science and Education (ORISE), Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439 |
| authorships[0].affiliations[1].raw_affiliation_string | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[0].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[0].institutions[1].id | https://openalex.org/I4210121439 |
| authorships[0].institutions[1].ror | https://ror.org/02ggwpx62 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sanjida J. Mowla |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA, Oak Ridge Institute for Science and Education (ORISE), Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[1].author.id | https://openalex.org/A5045250519 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3233-9466 |
| authorships[1].author.display_name | Ian Kracalik |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[1].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[1].institutions[1].id | https://openalex.org/I4210121439 |
| authorships[1].institutions[1].ror | https://ror.org/02ggwpx62 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ian T. Kracalik |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[2].author.id | https://openalex.org/A5071713826 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6938-6683 |
| authorships[2].author.display_name | Mathew R. P. Sapiano |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[2].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[2].institutions[1].id | https://openalex.org/I4210121439 |
| authorships[2].institutions[1].ror | https://ror.org/02ggwpx62 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mathew R.P. Sapiano |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[3].author.id | https://openalex.org/A5016212337 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Lynne O'Hearn |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1338449461, https://openalex.org/I166722992 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pathology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1338449461 |
| authorships[3].institutions[0].ror | https://ror.org/01q2nz307 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1338449461 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Baystate Medical Center |
| authorships[3].institutions[1].id | https://openalex.org/I166722992 |
| authorships[3].institutions[1].ror | https://ror.org/0464eyp60 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I166722992 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | University of Massachusetts Chan Medical School |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lynne O'Hearn |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pathology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA |
| authorships[4].author.id | https://openalex.org/A5089839795 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3120-9010 |
| authorships[4].author.display_name | Chester Andrzejewski |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1338449461, https://openalex.org/I166722992 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pathology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I1338449461 |
| authorships[4].institutions[0].ror | https://ror.org/01q2nz307 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1338449461 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Baystate Medical Center |
| authorships[4].institutions[1].id | https://openalex.org/I166722992 |
| authorships[4].institutions[1].ror | https://ror.org/0464eyp60 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I166722992 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of Massachusetts Chan Medical School |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Chester Andrzejewski |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pathology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA |
| authorships[5].author.id | https://openalex.org/A5030672676 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8376-0499 |
| authorships[5].author.display_name | Sridhar V. Basavaraju |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[5].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[5].institutions[1].id | https://openalex.org/I4210121439 |
| authorships[5].institutions[1].ror | https://ror.org/02ggwpx62 |
| authorships[5].institutions[1].type | facility |
| authorships[5].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Sridhar V. Basavaraju |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8175014 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10693 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9991000294685364 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2704 |
| primary_topic.subfield.display_name | Biochemistry |
| primary_topic.display_name | Blood transfusion and management |
| related_works | https://openalex.org/W2361645227, https://openalex.org/W1997832982, https://openalex.org/W2372771645, https://openalex.org/W2590837098, https://openalex.org/W2032504685, https://openalex.org/W2431889647, https://openalex.org/W2375003523, https://openalex.org/W1963507424, https://openalex.org/W2387587816, https://openalex.org/W2089577000 |
| cited_by_count | 25 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 7 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 7 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:8175014 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Transfus Med Rev |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8175014 |
| primary_location.id | doi:10.1016/j.tmrv.2021.03.003 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S162247841 |
| primary_location.source.issn | 0887-7963, 1532-9496 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0887-7963 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Transfusion Medicine Reviews |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Transfusion Medicine Reviews |
| primary_location.landing_page_url | https://doi.org/10.1016/j.tmrv.2021.03.003 |
| publication_date | 2021-04-01 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W6773847244, https://openalex.org/W1694352266, https://openalex.org/W6698075505, https://openalex.org/W2347529944, https://openalex.org/W2261388999, https://openalex.org/W2032345993, https://openalex.org/W2164991961, https://openalex.org/W2567714701, https://openalex.org/W2415256878, https://openalex.org/W1505823895, https://openalex.org/W4242449005, https://openalex.org/W1483788291, https://openalex.org/W2118783000, https://openalex.org/W2898547995, https://openalex.org/W2788726535, https://openalex.org/W2952050594, https://openalex.org/W2616620644, https://openalex.org/W2116031612, https://openalex.org/W2045212571, https://openalex.org/W2753528088, https://openalex.org/W2950211756, https://openalex.org/W2901166194, https://openalex.org/W3008259259, https://openalex.org/W2308329744 |
| referenced_works_count | 24 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5085610975 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6899999976158142 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.81239578 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |